Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA’s “Dear Doc” Final Guidance Yields To One Industry Request, Denies Another

This article was originally published in The Pink Sheet Daily

Executive Summary

Agency offers a sneak peek into final “Dear Health Care Provider Letters” guidance, decreasing some of industry’s burden, while refusing to cave on other requirements.

Advertisement

Related Content

How To Write An Effective Letter: FDA Advises Sponsors On Crafting Drug Alerts
FDA Standardizing “Dear Doc” Letters To Fix Problems With Recipients As Much As Senders
FDA Wants To Consult Before Manufacturers Send "Dear Doc" Letters

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS076076

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel